{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:01:46Z","timestamp":1784811706150,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","award":["SYYYRC-2023007"],"award-info":[{"award-number":["SYYYRC-2023007"]}],"id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020771","name":"Natural Science Foundation for Young Scientists of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100406"],"award-info":[{"award-number":["82100406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024D067"],"award-info":[{"award-number":["2024D067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179049","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:54:00Z","timestamp":1780012440000},"page":"179049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SGLT2 inhibitors ameliorate myocardial hypertrophy in rats via AMPK\/Nrf2-mediated ferroptosis suppression and antioxidant response"],"prefix":"10.1016","volume":"1029","author":[{"given":"Jiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7439-0108","authenticated-orcid":false,"given":"Hong-tao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179049_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12933-024-02481-y","article-title":"Dapagliflozin mitigates cellular stress and inflammation through PI3K\/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived \u03b2 cells","volume":"23","author":"Alsereidi","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.179049_bib2","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/eurheartj\/ehad283","article-title":"Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial","volume":"44","author":"Chatur","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179049_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.ejphar.2026.179049_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103230","article-title":"\u03b1-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1\u03b1\/Nrf2 pathway","volume":"74","author":"Cheng","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1\u2010NRF2 protein\u2013protein interaction inhibitors: design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2026.179049_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174858","article-title":"Acacetin ameliorates cardiac hypertrophy by activating Sirt1\/AMPK\/PGC-1\u03b1 pathway","volume":"920","author":"Cui","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179049_bib7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179049_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib9","article-title":"Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2\/HO-1\/GPX4 signaling pathway","volume":"20","author":"Fan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179049_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179049_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060867","article-title":"New insights into the role of ferroptosis in cardiovascular diseases","volume":"12","author":"Fratta Pasini","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179049_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.07.031","article-title":"NF\u03baB promotes oxidative stress-induced necrosis and ischemia\/reperfusion injury by inhibiting Nrf2-ARE pathway","volume":"159","author":"Guo","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179049_bib13","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.7150\/thno.99340","article-title":"Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21","volume":"14","author":"Han","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.179049_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","article-title":"p62 links autophagy and Nrf2 signaling","volume":"88","author":"Jiang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179049_bib16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/MCB.00118-16","article-title":"AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550","volume":"36","author":"Joo","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jcmm.13038","article-title":"Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases","volume":"21","author":"Kander","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179049_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib19","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.109.189480","article-title":"Nrf2 protects against maladaptive cardiac responses to hemodynamic stress","volume":"29","author":"Li","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10715762.2023.2299359","article-title":"Omaveloxolone ameliorates isoproterenol-induced pathological cardiac hypertrophy in mice","volume":"58","author":"Li","year":"2024","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2026.179049_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109957","article-title":"GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress","volume":"117","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.179049_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13880209.2021.2007269","article-title":"Britanin relieves ferroptosis-mediated myocardial ischaemia\/reperfusion damage by upregulating GPX4 through activation of AMPK\/GSK3\u03b2\/Nrf2 signalling","volume":"60","author":"Lu","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejphar.2026.179049_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179049_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179049_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.07.014","article-title":"AMPK and NRF2: interactive players in the same team for cellular homeostasis?","volume":"190","author":"Petsouki","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179049_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jep.2015.04.004","article-title":"Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy","volume":"168","author":"Qu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.179049_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076723","article-title":"Mitigation of cardiovascular disease and toxicity through NRF2 signalling","volume":"24","author":"Roberts","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179049_bib28","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1182\/blood-2012-04-422121","article-title":"The high Nrf2 expression in human acute myeloid leukemia is driven by NF-\u03baB and underlies its chemo-resistance","volume":"120","author":"Rushworth","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.179049_bib29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179049_bib30","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179049_bib31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.179049_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113572","article-title":"Dexmedetomidine attenuates myocardial ischemia\/reperfusion-induced ferroptosis via AMPK\/GSK-3\u03b2\/Nrf2 axis","volume":"154","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179049_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2026.179049_bib34","article-title":"AMPK, mitochondrial function, and cardiovascular disease","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179049_bib35","article-title":"Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1\/HIF-1\u03b1 signaling pathway","volume":"165","author":"Yang","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2026.179049_bib36","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s11010-025-05294-z","article-title":"SGLT2i continuously prevents cardiac hypertrophy by reducing ferroptosis via AMPK up-regulation","volume":"480","author":"Zhao","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.179049_bib37","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-024-46357-x","article-title":"ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice","volume":"15","author":"Zhuang","year":"2024","journal-title":"Nat. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:14:21Z","timestamp":1784808861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0014299926005315"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179049","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitors ameliorate myocardial hypertrophy in rats via AMPK\/Nrf2-mediated ferroptosis suppression and antioxidant response","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179049"}}